Moveltipril calcium

CAS: 85921-53-5

Rif. 3D-FM148293

Informazioni sul prodotto

• Nome: Moveltipril calcium
• Sinonimi: <span class="text-smallcaps">L</smallcap>-Proline, N-(cyclohexylcarbonyl)-<smallcap>D</span>-alanyl-(2S)-3-mercapto-2-methylpropanoyl-, calcium salt (2:1), <span class="text-smallcaps">L</span>-Proline, 1-[(2S)-3-[[(2R)-2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-, calcium salt (2:1), <span class="text-smallcaps">L</span>-Proline, 1-[3-[[2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-, calcium salt (2:1), [R-(R*,S*)]-, Altiopril calcium, Calcium (2R)-1-[(2R)-3-[2-(cyclohexanecarbonylamino)propanoylsulfanyl]-2-methylpropanoyl]pyrrolidine-2-carboxylate, Lowpres, Mc 838, L-Proline, N-(cyclohexylcarbonyl)-D-alanyl-(2S)-3-mercapto-2-methylpropanoyl-, calcium salt (2:1), L-Proline, 1-[3-[[2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-, calcium salt (2:1), [R-(R*,S*)]-

Descrizione

Moveltipril calcium is a calcium salt of the pressor moveltipril. It is used to treat inflammatory bowel disease and high blood pressure. Moveltipril calcium is a prodrug that is hydrolyzed in vivo to moveltipril, its active form. Moveltipril increases the blood pressure by blocking the production of angiotensin II and has been shown to have beneficial effects on insulin resistance in patients with type 2 diabetes mellitus. The pharmacokinetic properties of moveltipril calcium are linear, with a terminal half-life of about 18 hours. This drug can be administered orally and has few adverse effects.

• Marchio: Biosynth

Proprietà chimiche

• Peso molecolare: 835.1 g/mol
• Formula: C₃₈H₅₈CaN₄O₁₀S₂
• Purezza: Min. 95%